Related Experiment Video
Updated: Jul 26, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
Marketing and commercial challenges for anticancer products
1Schering-Plough Corporation, Oncology/Biotechnology Business Unit, Kenilworth, NJ 07033, USA.
Traditional pharmaceutical marketing fails in oncology due to unique challenges. Effective strategies must provide timely, comprehensive information to healthcare providers within legal limits, supporting physician and patient choices in cancer care.
Area of Science:
- Oncology
- Pharmaceutical Marketing
- Healthcare Management
Background:
- Traditional marketing approaches are insufficient for the specialized oncology sector.
- The oncology market presents unique challenges for pharmaceutical sales and marketing teams.
- Anticancer and supportive care products require distinct marketing strategies.
Purpose of the Study:
- To highlight the inadequacy of traditional marketing in oncology.
- To identify the unique challenges in marketing oncology products.
- To emphasize the need for effective information dissemination in cancer care.
Main Methods:
- Analysis of traditional marketing techniques in the pharmaceutical industry.
- Identification of specific characteristics of the oncology therapeutic area.
- Examination of information dissemination burdens and legal constraints.
Main Results:
- Standard marketing methods do not meet the demands of the oncology setting.
- Marketing oncology products requires providing extensive information promptly to diverse healthcare providers.
- Legal boundaries significantly impact marketing and sales efforts.
Conclusions:
- Pharmaceutical marketing in oncology necessitates specialized strategies.
- Timely and comprehensive information is crucial for healthcare providers' decision-making.
- Marketing efforts should support, not restrict, physician and patient autonomy in cancer treatment.
More Related Videos
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Clinical Trials: Overview